Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeFDAHomtex, Receives FDA Approval For Its Level 1 Surgical Masks

Homtex, Receives FDA Approval For Its Level 1 Surgical Masks

9 of the Highest Paying Travel Nursing Specialties

The highest paying travel nursing specialties tend to offer significantly higher pay rates and benefits than their non-traveling counterparts. Learn More.

Involved in a Car-Truck Collision? Here’s How to Deal With the Aftermath

It can be challenging to know how to proceed when the unthinkable happens, and you are involved in a car-truck collision. You may have...

Why Every Healthcare Organization Should Embrace A Lean Approach

Quality, efficiency, and safety determine the success of a business in any domain. The healthcare industry is not an exception. Rather, providers need to...

How Advancements in Technology is Changing the Medical Industry

As with many industries, the healthcare industry is growing pretty rapidly. As technology advances, the medical industry has benefitted more than any other. Medical...

How Healthcare Professionals Can Benefit From Deployable Field Hospitals

Read on to find out what deployable field hospitals are and at least five ways healthcare professionals can benefit from deployable field hospitals.

6 Tips That Will Help You Pass Your USMLE Exam

It's that time of year again. If you are a medical student, then that means it is time to take your USMLE exam. This...

March 15, 2021

HomTex, an Alabama-based, minority-certified textile manufacturer manufactures 3-ply disposable masks and reusable cloth masks, which it supplies to the US Capitol, and soon will produce NIOSH N-95 masks in a new plant in Selma, Alabama.

HomTex is now positioned to have the largest capacity in the US to produce 100 percent made-in-America masks with facilities in Cullman and Mobile, Alabama; Tennessee; South Carolina; and North Carolina.

Jerry Wooten, CEO of HomTex, said “When I say made in America, I mean every component sourced in the US and made in the US.  We believe that ramping up domestic manufacturing of PPE products is a national imperative from a safety, economic, and national security perspective, and HomTex is proud to meet that challenge.”

While hospitals and governments have been struggling to provide safe PPE for Americans, defective and fraudulent masks, often made in China, have flooded the US market. According to the Associated Press, federal law enforcement has seized 10 million counterfeit N95 masks alone, and the US Customs and Border Patrol announced in June 2020 that it seized 750,000 counterfeit face masks in 86 incidents.  Due to emergency procurement rules put in place during the pandemic, China and other bad actors have access to the US market that otherwise would be banned.  By selling defective and counterfeit masks at rock-bottom prices, fraudsters are exploiting US buyers with unsafe PPE and undermining US-made manufacturing.

According to Wooten, “It’s time for purchasers of critical PPE – particularly federal, state, and local governments – to wake up to the fact that Chinese and foreign-made masks are cheaper, but likely defective, counterfeit, and plain-old dangerous. It’s important to buy safe, genuine, and approved PPE from a trusted made-in-America manufacturer.  We are proud to be a strategic provider to the Architect of the US Capitol which supplies masks to the US House of Representatives, the US Capitol, and the US Senate.”

“We are immensely proud of all HomTex is doing to produce PPE,” said Katie Boyd Britt, President of the Business Council of Alabama. “Receiving this critical authorization from the FDA allows them to expand their PPE offerings and to keep Americans safe. We are thrilled to be a trusted partner as they expand their operations in Selma.”

HomTex has the capacity to produce 700 million surgical 3-ply masks and 20 million NIOSH N-95 masks annually.  HomTex will open an additional manufacturing facility in Selma, AL in the Fall of 2021 that will create 300 jobs for the most economically disadvantaged region of Alabama.

spot_img

DON'T MISS

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

Alpha Tau Receives FDA’s Breakthrough Device Designation for the RX of Recurrent Glioblastoma Multiforme

"As GBM is such a terrible disease, it is critical that we find new solutions for these patients, and we are thrilled that receipt of the FDA's Breakthrough Device Designation will allow us to expedite our clinical collaborations with leading cancer centers in the U.S. and across the world, and to bring new hope for GBM patients.

FDA Announces Signing of Domestic Mutual Reliance Agreements with California, Florida, Utah and Wisconsin

These Mutual Reliance agreements facilitate a coordinated effort between the FDA and individual states with goals to reduce human foodborne illness outbreaks, reduce duplication of regulatory oversight and increase public health protection by focusing on areas of higher risk.

SyncThink Receives Second FDA Clearance for EYE-SYNC Platform; the First Mobile, Rapid Test for Concussion

EYE-SYNC previously received the prestigious Breakthrough Device Designation from the FDA in 2019, following the initial clearance and commercialization of the technology platform in 2017.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy